We are evaluating a new treatment for early-stage non-squamous non-small cell lung cancer to see how it compares to Keytruda after surgery and chemotherapy. This study aims to understand if the new drug works similarly in the body.
Health conditions and diseases that the clinical trial is designed to study and treat.
Early-stage Non-squamous Non-small Cell Lung Cancer (NSCLC) is a type of lung cancer that begins in the lungs and is characterized by the absence of squamous cells. This stage indicates that the cancer is still localized and has not spread extensively.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.
